awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34433926-CFFD046B-383B-40B4-9292-36C8A7966362
Q34433926-CFFD046B-383B-40B4-9292-36C8A7966362
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34433926-CFFD046B-383B-40B4-9292-36C8A7966362
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relap
P50
Q34433926-CFFD046B-383B-40B4-9292-36C8A7966362
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34433926-CFFD046B-383B-40B4-9292-36C8A7966362
rank
NormalRank
type
BestRank
Statement
P1545
2
http://www.w3.org/2001/XMLSchema#string
P1932
Peter Hillmen
http://www.w3.org/2001/XMLSchema#string
P50
Peter Hillmen